Prestin Inhibitors

Prestin inhibitors encompass a range of chemical entities that are known to modulate the activity of Prestin (SLC26A5), a motor protein found in the membrane of cochlear outer hair cells, crucial for sound amplification and frequency discrimination. These inhibitors, rather than acting through a unified chemical class, are diverse in structure and pharmacological activity, targeting various aspects of Prestin's function. Salicylates, such as aspirin, bind directly to Prestin and dampen its activity. Similarly, other small molecules like chloroquine and quinine can interact with the protein or the surrounding membrane to reduce Prestin's electromotive force. Certain loop diuretics, including furosemide and bumetanide, may interfere with Prestin function by disrupting the ionic gradients that are essential for its motor capability, thus indirectly inhibiting its activity. Aminoglycoside antibiotics like gentamicin can cause ototoxicity and have been shown to affect the activity of outer hair cells, presumably through interactions that lead to Prestin inhibition.

On the molecular level, these inhibitors could exert their effects by direct interaction with the protein, altering its conformation, or by modifying the lipid environment of the cell membrane, which is crucial for Prestin's optimal functionality. Other compounds may act by affecting the homeostasis of intracellular ions, particularly anions, which are essential for Prestin's operation as a voltage-driven motor. Some inhibitors, like DIDS, directly target anion transport mechanisms, while Ginkgolide B and anti-inflammatory agents are known to have broader cellular effects that could extend to include the modulation of Prestin function. This class of compounds serves as a critical tool for understanding the precise mechanisms of Prestin-mediated electromotility and the broader physiological processes that depend on this protein's activity.